Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 12;58(9):1261.
doi: 10.3390/medicina58091261.

Post-ERCP Pancreatitis: Prevention, Diagnosis and Management

Oscar Cahyadi  1 , Nadeem Tehami  2 , Enrique de-Madaria  3   4 , Keith Siau  5   6
Affiliations
Review

Post-ERCP Pancreatitis: Prevention, Diagnosis and Management

Oscar Cahyadi et al. Medicina (Kaunas). .

Abstract

Endoscopic retrograde cholangiopancreatography (ERCP) carries a post-ERCP pancreatitis (PEP) rate of 2-10%, which could be as high as 30-50% in high-risk cases. PEP is severe in up to 5% of cases, with potential for life-threatening complications, including multi-organ failure, peripancreatic fluid collections, and death in up to 1% of cases. The risk of PEP is potentially predictable and may be modified with pharmacological measures and endoscopist technique. This review covers the definition, epidemiology and risk factors for PEP, with a focus on the latest evidence-based medical and endoscopic strategies to prevent and manage PEP.

Keywords: ERCP; non-steroidal anti-inflammatory drugs; pancreatic stenting; post-ERCP pancreatitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
A proposed classification of the papilla morphology and the associated difficulty during bile duct cannulation. * Significantly higher risk vs. Type 1 papillae.
See this image and copyright information in PMC

References

    1. Dumonceau J.-M., Kapral C., Aabakken L., Papanikolaou I.S., Tringali A., Vanbiervliet G., Beyna T., Dinis-Ribeiro M., Hritz I., Mariani A., et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020;52:127–149. doi: 10.1055/a-1075-4080. - DOI - PubMed
    1. Cotton P.B., Lehman G., Vennes J., Geenen J.E., Russell R.C., Meyers W.C., Liguory C., Nickl N. Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest. Endosc. 1991;37:383–393. doi: 10.1016/S0016-5107(91)70740-2. - DOI - PubMed
    1. Freeman M.L., Nelson D.B., Sherman S., Haber G.B., Herman M.E., Dorsher P.J., Moore J.P., Fennerty M.B., Ryan M.E., Shaw M.J., et al. Complications of endoscopic biliary sphincterotomy. N. Engl. J. Med. 1996;335:909–918. doi: 10.1056/NEJM199609263351301. - DOI - PubMed
    1. Banks P.A., Bollen T.L., Dervenis C., Gooszen H.G., Johnson C.D., Sarr M.G., Tsiotos G.G., Vege S.S., Acute Pancreatitis Classification Working Group Classification of acute pancreatitis—2012: Revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102–111.e9. doi: 10.1136/gutjnl-2012-302779. - DOI - PubMed
    1. Kochar B., Akshintala V.S., Afghani E., Elmunzer B.J., Kim K.J., Lennon A.M., Khashab M.A., Kalloo A.N., Singh V.K. Incidence, severity, and mortality of post-ERCP pancreatitis: A systematic review by using randomized, controlled trials. Gastrointest. Endosc. 2015;81:143–149.e9. doi: 10.1016/j.gie.2014.06.045. - DOI - PubMed

MeSH terms

Substances